stocrin 600mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - efavirenz - film tableta - 600mg
norvir 100mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - ritonavir - film tableta - 100mg
gilestra 245mg film tableta
"evropa lek pharma" doo podgorica - tenofovir dizoproksil - film tableta - 245mg
isentress 600mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - raltegravir - film tableta - 600mg
isentress 400mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - raltegravir - film tableta - 400mg
zyllt 75mg film tableta
dio stranog druŠtva "krka d.d. novo mesto" slovenija - predstavniŠtvo podgorica - klopidogrel - film tableta - 75mg
combivir 300 mg + 150 mg film tableta
glaxosmithkline export limited, velika britanija-dsd, podgorica - zidovudin, lamivudin - film tableta - 300 mg + 150 mg
epivir 150mg film tableta
glaxosmithkline export limited, velika britanija-dsd, podgorica - lamivudin - film tableta - 150mg
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - klopidogrel besilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotska sredstva - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). porastom segmenta st akutni infarkt miokarda, u kombinaciji s ask u liječenju pacijenata koji imaju pravo na thrombolytic terapije. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. za više informacija, molimo pogledajte odjeljak 5.
clopidogrel bgr (previously zylagren)
biogaran - clopidogrel (as hydrogen sulfate) - peripheral vascular diseases; stroke; myocardial infarction - antitrombotska sredstva - sprječavanje атеротромботических događaja klopidogrel prikazan:odrasli pacijenti koji pate инфарктом miokarda (od nekoliko dana do manje od 35 dana), ishemijski moždani udar (od 7 dana prije manje od 6 mjeseci) ili instaliranim bolest perifernih arterija.